Bioreactor-based engineering of osteochondral grafts: from model systems to tissue manufacturing.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 16384786)

Published in J Biosci Bioeng on November 01, 2005

Authors

David Wendt1, Marcel Jakob, Ivan Martin

Author Affiliations

1: Institute for Surgical Research and Hospital Management, University Hospital Basel, Hebelstrasse 20, Switzerland.

Articles by these authors

Cell differentiation by mechanical stress. FASEB J (2001) 2.56

Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials (2002) 2.22

Early detection of aging cartilage and osteoarthritis in mice and patient samples using atomic force microscopy. Nat Nanotechnol (2009) 2.19

Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci U S A (2010) 1.96

Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum (2003) 1.90

Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng (2006) 1.86

Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarthritis Cartilage (2004) 1.84

Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem (2002) 1.66

Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials (2005) 1.61

Osteochondral tissue engineering. J Biomech (2006) 1.57

Engineering of a functional bone organ through endochondral ossification. Proc Natl Acad Sci U S A (2013) 1.55

Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study. J Cell Physiol (2005) 1.49

Osteoblastic differentiation of Wharton jelly biopsy specimens and their mesenchymal stromal cells after serum-free culture. Plast Reconstr Surg (2014) 1.43

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther (2007) 1.35

Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells (2005) 1.32

Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum (2002) 1.31

Three-dimensional perfusion culture of human adipose tissue-derived endothelial and osteoblastic progenitors generates osteogenic constructs with intrinsic vascularization capacity. Stem Cells (2007) 1.27

Micro- and nanomechanical analysis of articular cartilage by indentation-type atomic force microscopy: validation with a gel-microfiber composite. Biophys J (2010) 1.26

In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials (2005) 1.26

Three-dimensional tissue engineering of hyaline cartilage: comparison of adult nasal and articular chondrocytes. Tissue Eng (2002) 1.26

Visual histological grading system for the evaluation of in vitro-generated neocartilage. Tissue Eng (2006) 1.23

New dimensions in tumor immunology: what does 3D culture reveal? Trends Mol Med (2008) 1.22

Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. J Cell Physiol (2012) 1.21

Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity. Arthritis Rheum (2007) 1.20

Cartilage tissue engineering for degenerative joint disease. Adv Drug Deliv Rev (2006) 1.18

Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. Cell Stem Cell (2012) 1.16

Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord (2010) 1.15

Orderly osteochondral regeneration in a sheep model using a novel nano-composite multilayered biomaterial. J Orthop Res (2010) 1.14

Design of graded biomimetic osteochondral composite scaffolds. Biomaterials (2008) 1.12

Lubricin reduces cartilage--cartilage integration. Biorheology (2004) 1.12

Cell yield, proliferation, and postexpansion differentiation capacity of human ear, nasal, and rib chondrocytes. Tissue Eng (2004) 1.09

Toward modeling the bone marrow niche using scaffold-based 3D culture systems. Biomaterials (2010) 1.07

Anabolic and catabolic responses of human articular chondrocytes to varying oxygen percentages. Arthritis Res Ther (2010) 1.07

Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomaterials (2005) 1.07

FGF-2 enhances TGF-beta1-induced periosteal chondrogenesis. J Orthop Res (2004) 1.05

Precultivation of engineered human nasal cartilage enhances the mechanical properties relevant for use in facial reconstructive surgery. Ann Surg (2006) 1.03

Meniscus repair and regeneration: review on current methods and research potential. Eur Cell Mater (2013) 1.02

Enhancing the biological performance of synthetic polymeric materials by decoration with engineered, decellularized extracellular matrix. Biomaterials (2012) 1.01

Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model. Tissue Eng (2005) 1.01

Tissue engineering for total meniscal substitution: animal study in sheep model--results at 12 months. Tissue Eng Part A (2012) 1.01

Engineering of large osteogenic grafts with rapid engraftment capacity using mesenchymal and endothelial progenitors from human adipose tissue. Biomaterials (2011) 1.01

Engineering of osteoinductive grafts by isolation and expansion of ovine bone marrow stromal cells directly on 3D ceramic scaffolds. Biotechnol Bioeng (2006) 1.00

Growth factors for clinical-scale expansion of human articular chondrocytes: relevance for automated bioreactor systems. Tissue Eng (2007) 0.99

The multipotency of luteinizing granulosa cells collected from mature ovarian follicles. Stem Cells (2009) 0.98

Tissue engineering for total meniscal substitution: animal study in sheep model. Tissue Eng Part A (2008) 0.98

TGF-β-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms. J Cell Sci (2014) 0.97

Interleukin-1β modulates endochondral ossification by human adult bone marrow stromal cells. Eur Cell Mater (2012) 0.97

MSCs: science and trials. Nat Med (2013) 0.97

Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c. Stem Cells (2012) 0.95

Advanced bioreactor with controlled application of multi-dimensional strain for tissue engineering. J Biomech Eng (2002) 0.95

Expansion on specific substrates regulates the phenotype and differentiation capacity of human articular chondrocytes. J Cell Biochem (2006) 0.94

Three-dimensional cell culture and tissue engineering in a T-CUP (tissue culture under perfusion). Tissue Eng (2007) 0.94

Use of multicellular tumor spheroids to dissect endothelial cell-tumor cell interactions: a role for T-cadherin in tumor angiogenesis. FEBS Lett (2007) 0.93

Effect of three-dimensional expansion and cell seeding density on the cartilage-forming capacity of human articular chondrocytes in type II collagen sponges. J Biomed Mater Res A (2010) 0.93

Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets. Biochem Biophys Res Commun (2006) 0.92

Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells. Arthritis Rheum (2010) 0.92

In vitro platforms for tissue engineering: implications for basic research and clinical translation. J Tissue Eng Regen Med (2011) 0.92

Do we really need cartilage tissue engineering? Swiss Med Wkly (2009) 0.91

Erodible conducting polymers for potential biomedical applications. Angew Chem Int Ed Engl (2002) 0.90

Validation of an automated procedure to isolate human adipose tissue-derived cells by using the Sepax® technology. Tissue Eng Part C Methods (2012) 0.90

Adipose tissue-derived progenitors for engineering osteogenic and vasculogenic grafts. J Cell Physiol (2010) 0.90

A 3D in vitro bone organ model using human progenitor cells. Eur Cell Mater (2011) 0.90

Priming 3D cultures of human mesenchymal stromal cells toward cartilage formation via developmental pathways. Stem Cells Dev (2013) 0.90

Response of human engineered cartilage based on articular or nasal chondrocytes to interleukin-1β and low oxygen. Tissue Eng Part A (2011) 0.89

Human articular chondrocytes suppress in vitro proliferation of anti-CD3 activated peripheral blood mononuclear cells. J Cell Physiol (2006) 0.89

The influence of the scaffold design on the distribution of adhering cells after perfusion cell seeding. Biomaterials (2011) 0.89

Engineered cartilage maturation regulates cytokine production and interleukin-1β response. Clin Orthop Relat Res (2011) 0.89

Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β. Int J Cancer (2014) 0.88

Engineering human cell-based, functionally integrated osteochondral grafts by biological bonding of engineered cartilage tissues to bony scaffolds. Biomaterials (2010) 0.88

Enzymatic digestion of adult human articular cartilage yields a small fraction of the total available cells. Connect Tissue Res (2003) 0.88

The osteogenicity of implanted engineered bone constructs is related to the density of clonogenic bone marrow stromal cells. J Tissue Eng Regen Med (2007) 0.88

Potential and bottlenecks of bioreactors in 3D cell culture and tissue manufacturing. Adv Mater (2009) 0.87

Lumican inhibits collagen deposition in tissue engineered cartilage. Matrix Biol (2008) 0.86

Bioreactor based engineering of large-scale human cartilage grafts for joint resurfacing. Biomaterials (2010) 0.86

Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. Tissue Eng Part A (2009) 0.86

Assessment of nerve damage using a novel ultrasonic device for bone cutting. J Oral Maxillofac Surg (2008) 0.86

Intraoperative engineering of osteogenic grafts combining freshly harvested, human adipose-derived cells and physiological doses of bone morphogenetic protein-2. Eur Cell Mater (2012) 0.85

Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen. Ann Surg (2005) 0.85

Characterization of transcript levels for matrix molecules and proteases in ruptured human anterior cruciate ligaments. Connect Tissue Res (2005) 0.85

In vitro osteogenic differentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells. Ann Surg (2005) 0.85

Tendon healing: an overview of physiology, biology, and pathology of tendon healing and systematic review of state of the art in tendon bioengineering. Knee Surg Sports Traumatol Arthrosc (2013) 0.84

In vitro and in vivo validation of human and goat chondrocyte labeling by green fluorescent protein lentivirus transduction. Tissue Eng Part C Methods (2010) 0.84

Defining properties of neural crest-derived progenitor cells from the apex of human developing tooth. Tissue Eng Part A (2008) 0.84

In vitro characterization of immune-related properties of human fetal bone cells for potential tissue engineering applications. Tissue Eng Part A (2009) 0.83

Spatial and temporal patterns of bone formation in ectopically pre-fabricated, autologous cell-based engineered bone flaps in rabbits. J Cell Mol Med (2008) 0.83

Use of hydrodynamic forces to engineer cartilaginous tissues resembling the non-uniform structure and function of meniscus. Biomaterials (2006) 0.83

Tissue decellularization by activation of programmed cell death. Biomaterials (2013) 0.82

The role of 3D structure and protein conformation on the innate and adaptive immune responses to silk-based biomaterials. Biomaterials (2013) 0.81

Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification. Tissue Eng Part C Methods (2011) 0.81

Differentiation-dependent up-regulation of BMP-2, TGF-beta1, and VEGF expression by FGF-2 in human bone marrow stromal cells. Plast Reconstr Surg (2005) 0.81